Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

DELP for Acute Hemorrhagic Stroke: a Prospective, Random, Open-label, Blind-endpoint, Single Centre, Pilot Study

NCT04708990 is registered in ClinicalTrials.gov with General Hospital of Shenyang Military Region as lead sponsor.

NCT NCT04708990
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04708990 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
DELP for Acute Hemorrhagic Stroke: a Prospective, Random, Open-label, Blind-endpoint, Single Centre, Pilot Study
Lead sponsor
General Hospital of Shenyang Military Region
Phase
Phase 2
Overall status
Terminated
Start date
January 12, 2021
Completion date
July 30, 2021
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cerebral hemorrhage